# Immunosuppressive Preparation Followed by Blood Cell Transplant for the Treatment of Blood Cancers in Older Adults

> **NCT00001637** · PHASE2 · COMPLETED · sponsor: **National Heart, Lung, and Blood Institute (NHLBI)** · enrollment: 28 (actual)

## Conditions studied

- Chronic Lymphocytic Leukemia
- Graft vs Host Disease
- Leukemia
- Myelodysplastic Syndrome
- Myeloid Leukemia

## Interventions

- **PROCEDURE:** Blood cell transplantation

## Key facts

- **NCT ID:** NCT00001637
- **Lead sponsor:** National Heart, Lung, and Blood Institute (NHLBI)
- **Sponsor class:** NIH
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 1997-09-29
- **Primary completion:** 2008-07-28
- **Final completion:** 2016-12-28
- **Target enrollment:** 28 (ACTUAL)
- **Last updated:** 2019-12-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00001637

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00001637, "Immunosuppressive Preparation Followed by Blood Cell Transplant for the Treatment of Blood Cancers in Older Adults". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT00001637. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*